Calls Now Open
2026 Scholar-Innovator, Harrington Prize and ADDF-Harrington
Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See All DiscoveriesBy concentrating philanthropic, scientific, and business development resources during the high-risk stages of drug development, Harrington ‘de-risks’ therapeutic candidates and positions them for further investment and commercialization.
Learn More
Call for proposals on proteostasis and senescence are particularly encouraged, alongside all novel approaches to treating Alzheimer’s disease
Continue Reading
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation
Continue Reading
Unique program for physician-scientists to advance promising discoveries into medicines
Continue Reading
2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies
Continue Reading